Leonidas Stamatatos

15.5k total citations · 2 hit papers
132 papers, 8.6k citations indexed

About

Leonidas Stamatatos is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Leonidas Stamatatos has authored 132 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Virology, 78 papers in Immunology and 45 papers in Infectious Diseases. Recurrent topics in Leonidas Stamatatos's work include HIV Research and Treatment (108 papers), Immune Cell Function and Interaction (66 papers) and HIV/AIDS drug development and treatment (35 papers). Leonidas Stamatatos is often cited by papers focused on HIV Research and Treatment (108 papers), Immune Cell Function and Interaction (66 papers) and HIV/AIDS drug development and treatment (35 papers). Leonidas Stamatatos collaborates with scholars based in United States, South Africa and Greece. Leonidas Stamatatos's co-authors include Cecilia Cheng‐Mayer, Andrew T. McGuire, D. Noah Sather, John R. Mascola, Dennis R. Burton, Susan W. Barnett, William R. Schief, John R. Silvius, Lynn Morris and Spyros A. Kalams and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Leonidas Stamatatos

130 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Immunodeficiency Virus Type 1envClones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

2005 845 citations Leonidas Stamatatos, Peter B. Gilbert et al. Journal of Virology profile →
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors

2013 529 citations Andrew T. McGuire, Andrew B. Ward et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leonidas Stamatatos United States	50	6.2k	4.4k	2.8k	2.6k	1.8k	132	8.6k
Per Johan Klasse United States	56	6.5k 1.1×	3.9k 0.9×	2.6k 0.9×	3.2k 1.2×	2.0k 1.1×	153	9.4k
James Μ. Binley United States	46	7.6k 1.2×	4.3k 1.0×	2.2k 0.8×	3.2k 1.2×	2.4k 1.3×	80	8.8k
Gabriela Stiegler United States	36	6.0k 1.0×	3.8k 0.9×	2.4k 0.8×	2.3k 0.9×	2.0k 1.1×	47	7.8k
Pascal Poignard United States	37	5.1k 0.8×	3.6k 0.8×	1.8k 0.6×	1.9k 0.7×	1.9k 1.0×	69	6.7k
James Arthos United States	45	5.5k 0.9×	4.9k 1.1×	1.9k 0.7×	2.1k 0.8×	1.1k 0.6×	113	8.4k
Miroslaw K. Górny United States	49	5.9k 1.0×	3.7k 0.9×	1.8k 0.6×	2.4k 0.9×	2.4k 1.3×	152	7.2k
William C. Olson United States	47	4.3k 0.7×	3.0k 0.7×	2.3k 0.8×	2.3k 0.9×	2.1k 1.2×	142	7.7k
Julie M. Decker United States	34	7.8k 1.3×	3.7k 0.8×	2.1k 0.7×	4.0k 1.5×	1.1k 0.6×	49	8.9k
Michael B. Zwick United States	44	5.5k 0.9×	3.3k 0.8×	3.4k 1.2×	2.0k 0.7×	3.2k 1.8×	77	8.2k
Alexandra Trkola Switzerland	54	9.1k 1.5×	5.6k 1.3×	2.9k 1.0×	4.7k 1.8×	2.3k 1.2×	147	12.0k

Countries citing papers authored by Leonidas Stamatatos

Since Specialization

Citations

This map shows the geographic impact of Leonidas Stamatatos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonidas Stamatatos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonidas Stamatatos more than expected).

Fields of papers citing papers by Leonidas Stamatatos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonidas Stamatatos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonidas Stamatatos. The network helps show where Leonidas Stamatatos may publish in the future.

Co-authorship network of co-authors of Leonidas Stamatatos

This figure shows the co-authorship network connecting the top 25 collaborators of Leonidas Stamatatos. A scholar is included among the top collaborators of Leonidas Stamatatos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonidas Stamatatos. Leonidas Stamatatos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dopico, Xaquín Castro, et al.. (2025). Antigen affinity and site of immunization dictate B cell recall responses. Cell Reports. 44(1). 115221–115221. 1 indexed citations

Schaefer-Babajew, Dennis, Claudia R. Ruprecht, Mohamed ElTanbouly, et al.. (2025). Antibody Mediated Diversification of Primary and Secondary Humoral Immune Responses. bioRxiv (Cold Spring Harbor Laboratory).

Gray, Matthew D., Junli Feng, Connor Weidle, et al.. (2022). Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain. Science Advances. 8(18). eabm3948–eabm3948. 2 indexed citations

Hurlburt, Nicholas K., Leah J. Homad, Irika R. Sinha, et al.. (2022). Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit. Communications Biology. 5(1). 342–342. 48 indexed citations

Zhao, Lue Ping, Terry P. Lybrand, Peter B. Gilbert, et al.. (2021). Tracking SARS-CoV-2 Spike Protein Mutations in the United States (January 2020—March 2021) Using a Statistical Learning Strategy. Viruses. 14(1). 9–9. 9 indexed citations

Hartweger, Harald, Andrew T. McGuire, Justin J. Taylor, et al.. (2019). HIV-specific humoral immune responses by CRISPR/Cas9-edited B cells. The Journal of Experimental Medicine. 216(6). 1301–1310. 71 indexed citations

Dosenovic, Pia, Ervin E. Kara, Andrew T. McGuire, et al.. (2018). Anti–HIV-1 B cell responses are dependent on B cell precursor frequency and antigen-binding affinity. Proceedings of the National Academy of Sciences. 115(18). 4743–4748. 67 indexed citations

Behrens, Sabine, Celia C. LaBranche, Taicheng Zhou, et al.. (2018). Germline-targeting and Reverse Engineering to Elicit CH235.12 Lineage bNAbs. AIDS Research and Human Retroviruses. 34. 116–116. 1 indexed citations

Hessell, Ann J., Delphine C. Malherbe, Franco Pissani, et al.. (2016). Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens. The Journal of Immunology. 196(7). 3064–3078. 34 indexed citations

10.

Sather, D. Noah, Sara Carbonetti, Delphine C. Malherbe, et al.. (2014). Development of Broadly Neutralizing Anti-HIV-1 Antibodies during Natural Infection through Early Epitope Acquisition and Subsequent Maturation. AIDS Research and Human Retroviruses. 30(S1). A35–A35. 1 indexed citations

11.

Sellhorn, George, Zane Kraft, Zachary Caldwell, et al.. (2011). Engineering, Expression, Purification, and Characterization of Stable Clade A/B Recombinant Soluble Heterotrimeric gp140 Proteins. Journal of Virology. 86(1). 128–142. 26 indexed citations

12.

Malherbe, Delphine C., Nicole A. Doria‐Rose, Lynda Misher, et al.. (2011). Sequential Immunization with a Subtype B HIV-1 Envelope Quasispecies Partially Mimics the In Vivo Development of Neutralizing Antibodies. Journal of Virology. 85(11). 5262–5274. 68 indexed citations

13.

Robinson, James E., Debra Elliott, David C. Montefiori, et al.. (2010). Quaternary Epitope Specificities of Anti-HIV-1 Neutralizing Antibodies Generated in Rhesus Macaques Infected by the Simian/Human Immunodeficiency Virus SHIV _SF162P4. Journal of Virology. 84(7). 3443–3453. 37 indexed citations

14.

Sather, D. Noah, Jakob Armann, Lance Ching, et al.. (2008). Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection. Journal of Virology. 83(2). 757–769. 402 indexed citations

15.

Kraft, Zane, Katharine Strouss, William F. Sutton, et al.. (2008). Characterization of Neutralizing Antibody Responses Elicited by Clade A Envelope Immunogens Derived from Early Transmitted Viruses. Journal of Virology. 82(12). 5912–5921. 19 indexed citations

16.

Derby, Nina, Sean A. Gray, Elizabeth A. Wayner, et al.. (2007). Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens. Virology. 366(2). 433–445. 23 indexed citations

17.

Xu, Rong, Indresh K. Srivastava, Catherine E. Greer, et al.. (2006). Characterization of Immune Responses Elicited in Macaques Immunized Sequentially with Chimeric VEE/SIN Alphavirus Replicon Particles Expressing SIVGag and/or HIVEnv and with Recombinant HIVgp140Env Protein. AIDS Research and Human Retroviruses. 22(10). 1022–1030. 28 indexed citations

18.

Xu, Rong, Indresh K. Srivastava, LaRene Kuller, et al.. (2006). Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection. Virology. 349(2). 276–289. 30 indexed citations

19.

Haigwood, Nancy L. & Leonidas Stamatatos. (2003). Role of neutralizing antibodies in HIV infection. AIDS. 17(Supplement 4). 67–71. 19 indexed citations

20.

Stamatatos, Leonidas, et al.. (2000). Generation and Structural Analysis of Soluble Oligomeric gp140 Envelope Proteins Derived from Neutralization-Resistant and Neutralization-Susceptible Primary HIV Type 1 Isolates. AIDS Research and Human Retroviruses. 16(10). 981–994. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact